Before using this drug tell your doctor your medical history especially of ulcers, unusual menstrual periods, diabetes, liver or kidney disease, high blood pressure, arthritis, thyroid problems, all recent infections, if you have had recent surgery and of drug and food allergies.

The FDA has stated that certain generic warfarin products are interchangeable.

However, consult your doctor and pharmacist before switching warfarin products.

Do not stop taking any medications that you are currently taking unless directed to do so by your doctor.

If you have an illness that causes vomiting, diarrhea, or fever for more than a few days, contact your doctor as these problems can change the effect of this drug.

Limit your consumption of alcoholic beverages.

Ask your doctor how much, if any, alcohol you may consume.

In the event of an accidental overdose of this drug, contact your doctor, poison control center, or nearest hospital emergency department immediately.

When receiving warfarin, avoid sudden changes in dietary habits.

Avoid ingesting unusual increases or decreases of foods high in Vitamin K (liver, broccoli, cauliflower, cabbage, kale, spinach and other green leafy vegetables, green tea, certain vegetables, cheeses and certain vitamin supplements).

It is best to avoid strictly vegetarian diets that consist of foods high in vitamin K.

While taking this medication, be extra careful to avoid injuries.

This medication can cause heavy bleeding. Use an electric razor and be careful brushing your teeth.

Warfarin should not be used during pregnancy.

If you become pregnant or think you may be pregnant, inform your doctor immediately.

This drug is excreted into breast milk.

While to date, no problems have been noted in nursing infants, consult your doctor before you breast-feed.

For information on Medic Alert(TM) call 1-800-854-1166. In Canada call 1-800-668-1507.

Generic Name: Warfarin Sodium

Coumadin 10 mg Tablet - Prescription

Warfarin Sodium 10 mg Tablet - Prescription

Coumadin 2 mg Tablet - Prescription

Warfarin Sodium 2 mg Tablet - Prescription

Coumadin 1 mg Tablet - Prescription

Warfarin Sodium 1 mg Tablet - Prescription

Coumadin 5 mg Tablet - Prescription

Warfarin Sodium 5 mg Tablet - Prescription

Coumadin 2.5 mg Tablet - Prescription

Warfarin Sodium 2.5 mg Tablet - Prescription

Coumadin 7.5 mg Tablet - Prescription

Warfarin Sodium 7.5 mg Tablet - Prescription

Coumadin 3 mg Tablet - Prescription

Warfarin Sodium 3 mg Tablet - Prescription

Coumadin 4 mg Tablet - Prescription

Warfarin Sodium 4 mg Tablet - Prescription

Coumadin 6 mg Tablet - Prescription

Warfarin Sodium 6 mg Tablet - Prescription

20358s19lbl

http://www.fda.gov/cder/foi/label/2001/20358s19lbl.pdf

WELLBUTRIN, dose, tablets, depression, bupropion, patients, immediate-release formulation, treatment, administration, seizure, mg/day.

DESCRIPTION: WELLBUTRIN SR (bupropion hydrochloride), an antidepressant of the aminoketone class, is chemically unrelated to tricyclic, tetracyclic, selective serotonin re-uptake inhibitor, or other known antidepressant agents.

Three metabolites have been shown to be active: hydroxybupropion, which is formed via hydroxylation of the tert-butyl group of bupropion, and the amino-alcohol isomers threohydrobupropion and erythrohydrobupropion, which are formed via reduction of the carbonyl group.

No single dose should exceed 200 mg to avoid high peak concentrations of bupropion and/or its metabolites.

General: Agitation and Insomnia: Patients in placebo-controlled trials with WELLBUTRIN SR Tablets experienced agitation, anxiety, and insomnia as shown in Table 1.

Wellbutrin_NTB

http://www.pharmacist.com/pdf/Wellbutrin_NTB.pdf

depression, antidepressant, bupropion, patients, therapy, pharmacists, drug, disorders, medications, treatment, health care.

Depression is a leading cause of morbidity in the United States and by 2020 will be the second leading cause of worldwide health care morbidity.1 Approximately 16% of the population will suffer from a significant depressive episode in their lifetime and have an impaired quality of life.2 Despite recent advances in the treatment of depression, antidepressant therapy is associated with frequent, sometimes severe adverse effects and barriers to adherence.

Bupropion is a first-line agent for treating depression according to the American Psychiatric Association and has the advantage of few significant side effects and limited adverse effects on sexual functioning.3 In fact, bupropion has been shown to be effective as an augmenting agent to selective serotonin reuptake inhibitors (SSRIs) and to decrease sexual dysfunction associated with SSRIs when used as add-on therapy.4 A recently approved extended-release formulation of bupropion provides patients with an efficacious antidepressant with convenient once-daily dosing.

wellbutrin_zyban_hpc_e

health, Canada, reports, patients, agitation-type, drug, anti-depressants, Biovail Pharmaceuticals Canada, healthcare professionals, adverse, emotions.

As findings from post-market spontaneous reports regarding agitation type events apply to ZYBAN® as well as WELLBUTRIN® SR, the following Class warning is therefore being incorporated into the labelling of both products.

Please note that neither WELLBUTRIN® SR nor ZYBAN® have been fully evaluated in pediatrics, and these products are not indicated for use in patients less than 18 years of age.

There are clinical trial and post-marketing reports with SSRIs and other newer anti-depressants, in both pediatrics and adults, of severe agitation-type adverse events coupled with self-harm or harm to others.

Rigorous clinical monitoring for suicidal ideation or other indicators of potential for suicidal behaviour is advised in patients of all ages given an anti-depressant drug.